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Abstract
Background: Prospective studies on the risk factors for subarachnoid hemorrhage (SAH) are limited. Moreover, the effect of
risk factors on the incidence rates of SAH is not well known about.
Aims: In this study, we aimed to identify risk factors for SAH and characterize subgroups in a population with a high
incidence of SAH.
Methods: After recording multiple potential risk factors for SAH at the time of enrolment, first ever SAH events between
1972 and 2009 were recorded through the nationwide Causes of Death Register and Hospital Discharge Register for the
population-based cohort of 64 349 participants, who participated in the National FINRISK Study between 1972 and 2007 in
Finland.
Results: During the follow-up time of 1.26 million person-years (median 17.9 years, range 0 to 37.9 years), 437 persons
experienced fatal or non-fatal SAH. Crude SAH incidence was 34.8 (95% confidence interval: 31.7–38.2) per 100 000 person-
years among $25-year-old persons. Female sex, high blood pressure values and current smoking were confirmed as risk
factors for SAH. Previous myocardial infarction, history of premature stroke (any kind) in mother and elevated cholesterol
levels in men were identified as new risk factors for SAH. Depending on the combination of risk factors, SAH incidence
varied between 8 and 171 per 100 000 person-years.
Conclusions: New and previously reported risk factors appear to have a much stronger association with the incidence of
SAH than is ordinarily seen in cardiovascular diseases. Risk factor assessments may facilitate the identification of high-risk
persons who should be the focus of preventive interventions.
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Introduction
The number of publications reporting risk factors for subarach-
noid hemorrhage (SAH) are numerous, but only two large
population-based prospective studies on SAH risk factors with a
long (.10 years) follow-up time have been published to date [1,2].
The results of these studies suggest that increasing age, female sex,
hypertension and smoking are significant risk factors for SAH,
whereas a high body mass index (BMI) may even decrease the risk
of SAH [1,2]. The results of many case-control studies are in line
with these findings.
Using data from the ongoing national FINRISK Study [3],
which was initiated in 1972 and is comprised of 5-yearly cross-
sectional population surveys on risk factors of various diseases, we
identified risk factors for SAH in a population-based cohort of
nearly 65 000 Finnish citizens. Risk factor data was collected at
enrolment, and a register-based follow-up was conducted from the
enrolment to the onset of SAH, censoring, or the end of the follow-
up period in December 2009. In addition, by performing risk
factor profiling, we aimed to stratify subjects into subgroups with
exceptional high incidence rates of SAH.
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Methods
Ethics Statement
The approval for the FINRISK surveys has been applied each
time from corresponding ethics committees. Informed consent
(verbal until 1992 and written since 1997) was received from all
participants.
Data Collection
The data was drawn from the National FINRISK Study
database [3]. The FINRISK surveys were initiated in 1972 and
since then the surveys have been carried out every five years using
independent, random and representative population samples from
different geographical areas of Finland. Participants filled in a
health-related baseline questionnaire and attended a clinical
examination, which was conducted by trained research nurses at
enrollment.
A register-based follow-up (based on the Hospital Discharge
Register and the Causes of Death Register) was conducted for all
participants from the enrolment to the FINRISK study to the
onset of SAH (defined as first hospitalization for SAH or death
from SAH if no hospitalization), as described previously [4]. In
short, censoring occurred at the time of death or emigration (data
from the Finnish Population Register), or at the end of the follow-
up period in December 2009. The National Institute for Health
and Welfare administers the Hospital Discharge Register, which
includes the personal identification number, up to four discharge
diagnoses (the first diagnosis being the principal cause of hospital
stay), the dates of admission and discharge, and the hospital code.
The Causes of Death Register is administered by Statistics
Finland, where a specialist physician (forensic medicine) and a
nosologist check the consistency of the underlying cause of death,
and correct the diagnosis if necessary. Using the eight, ninth and
tenth revisions of the International Classification of Diseases
(ICD), incident cases of SAH were identified from the Hospital
Discharge Register and from the Causes of Death Register. Data
were retrieved on all persons listed with a diagnosis of SAH (ICD-8
and ICD-9 codes 430) or non-traumatic SAH (ICD-10 codes I60),
and identified cases were linked to the baseline data using the
personal identification number.
SAH Study Cohort
Persons with a non-fatal SAH before the baseline (i.e. no
prospective follow-up) were excluded. The SAH study cohort
consisted of 64 349 Finnish residents, of which 33 235 (51.7%)
were women. Mean age at enrolment was 45 years [standard
deviation (SD) 12 years, range 25 to 74 years] with no difference
by sex or future case status. In addition to the crude incidence of
SAH, a European age-standardized incidence rate per 100,000
person-years was calculated using the European standard popu-
lation to weight the age-specific rates.
Analyzed Risk Factors
Analyzed risk factors included age, sex and questionnaire
assessments (i.e. self-reporting) of smoking status, current alcohol
consumption (data was available for cohorts examined between
1982 and 1997), previously diagnosed hypertension, previous
stroke (any kind) (data was available for cohorts examined between
1982 and 2007), previous myocardial infarction (data was available
for cohorts examined between 1982 and 2007), history of
premature stroke [any kind of a stroke occurring before age 60
(cohort years 1972 to 1992) or 75 years (cohort years 2002 and
2007); age limit was not defined for the cohort year 1997] in father
and mother, and history of premature myocardial infarction in
father and mother [myocardial infarction/angina pectoris occur-
ring before age 60 (cohort years 1972, 1977, 1982 and 1987) or
myocardial infarction occurring before age 60 (cohort years 1992,
1997 and 2002) years; for the cohort year 2007, age limit for
myocardial infarction in men and women was 60 and 65 years,
respectively]. Current alcohol consumption was converted from
Frequency and Quantity items as grams per week. Since more
than 40% of the participants were non-regular users of alcohol,
they could not be divided into two separate categories. Therefore,
in order to divide alcohol consumption into fifths, we combined
two fifths to create the non-users. Clinically measured risk factors
included systolic and diastolic blood pressure (BP) (divided into
fifths), BMI based on measured weight and height, and total serum
cholesterol (divided into fifths).
Statistical Analyses
We used the Cox proportional hazards model to estimate
hazard ratios (HRs) of SAH with 95% confidence intervals. The
Table 1. Person-years, number of cases, unadjusted SAH incidence per 100 000 person-years (95% confidence intervals [CI]), and
case fatality of SAH by age group and sex.
Age (years) Person years SAH cases (women) Incidence (CI)
Incidence in
women (CI)
Incidence in
men (CI)
Case fatality %
(women/men)
#35 81 199 12 (3) 14.8 (8.4–26.0) 7.2 (2.3–22.4) 22.7 (11.8–43.7) 33.3 (66.7/22.2)
35.1–40 90 690 15 (8) 16.5 (10.0–27.4) 17.2 (8.6–34.5) 15.8 (7.5–33.1) 13.3 (12.5/14.3)
40.1–45 118 807 39 (23) 32.8 (24.0–44.9) 37.9 (25.2–57.0) 27.5 (16.9–45.0) 38.5 (39.1/37.5)
45.1–50 143 298 33 (16) 23.0 (16.4–32.4) 22.9 (13.4–35.8) 24.2 (15.0–38.9) 36.4 (43.8/29.4)
50.1–55 161 381 59 (23) 36.6 (28.3–47.2) 27.7 (18.4–41.6) 46.0 (33.2–63.8) 42.4 (34.8/47.2)
55.1–60 170 848 64 (33) 37.5 (29.3–47.9) 37.0 (26.3–52.0) 38.0 (26.7–54.0) 40.6 (36.4/45.2)
60.1–65 164 915 71 (36) 43.1 (34.1–54.3) 40.6 (29.3–56.3) 45.9 (33.0–63.9) 35.2 (33.3/37.1)
65.1–70 133 417 63 (38) 47.2 (36.9–60.4) 51.3 (37.3–70.5) 42.1 (28.5–62.3) 44.4 (36.8/56.0)
70.1–75 96 736 40 (26) 41.3 (30.3–56.4) 47.0 (32.0–69.0) 33.8 (20.0–57.1) 40.0 (38.5/42.9)
.75 85 242 41 (30) 43.0 (31.7–58.5) 49.8 (34.8–71.2) 31.5 (17.4–56.8) 53.7 (63.3/27.3)
All 1 256 535 437 (236) 34.8 (31.7–38.2) 35.1 (30.9–39.9) 34.4 (30.0–39.5) 40.0 (39.8/40.3)
doi:10.1371/journal.pone.0073760.t001
New SAH Risk Factors
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time scale for the model was age (not time since entry), which was
defined on the basis of birthdate, date at entry and date of exit
from the study. In detail, the time scale is defined by birthdate but
entry into the study was defined by the date of entry, and hence
the follow-up time started from the age when entry took place. Exit
took place at the time of diagnosis, censoring or end of follow-up.
The use of this time scale adjusts for age. Departure from the
proportional hazards assumption was evaluated by Schoenfeld
residuals and by inspection of the ‘‘log-log’’ plots. Univariate
analyses were adjusted for sex, and analyses were further stratified
into two groups by sex. Multivariate analyses were adjusted for
univariately identified risk factors, and also stratified by sex.
Further adjustment by the survey cycle (or the study region) did
not change results, and the survey cycle had no independent effect
on the risk of SAH. Stratification by sex was used to illustrate
possible modifications of HRs by sex, as also done previously [1].
Continuous risk factors were analyzed by categories based on
quintiles. All analyses were performed using the Stata statistical
software (Version 11.2 and 12.1, Stata Corp, College Station,
Texas).
Results
Characteristics of the SAH Cases
Completeness of follow-up was 100% for deaths and hospital-
izations. Only 0.4% of the FINRISK study participants are lost to
follow-up due to emigration [5]. During the follow-up period of 1
256 535 person-years, 437 out of 64 349 persons had a fatal or
non-fatal SAH (Table 1). The annual crude incidence of SAH was
34.8 per 100 000 person-years ($25-year-old persons) (Table 1).
The European standard population -adjusted incidence of SAH
per 100,000 person-years was 19.0. Median follow-up time was
17.9 years (range 0 to 37.9 years) for all persons, and 12.3 years
(range 0 to 37.7 years) for SAH cases. Median and mean age at
diagnosis was 59.6 and 59.3 years (SD 12.3 years, range 26.0 to
91.2 years), respectively. Median and mean age at diagnosis was
57.4 and 57.2 years (SD 11.8 years, range 26.0 to 90.1 years),
respectively, for men, and 61.8 and 61.0 years (SD 12.6 years,
range 32.7 to 91.2 years), respectively, for women. 54.0% of the
SAH cases were women (Table 1). Two-fifths (40.0%) died for
SAH (any time) of all SAH subjects, and case fatality varied
relatively little with age (Table 1). The prevalence of analyzed
SAH risk factors is presented in Table 2.
Univariate Analyses of Risk Factors for SAH
Age and sex. SAH incidence increased especially between
ages 45 and 70 years (Table 1). The incidence of SAH by 5-year
age groups varied from 7.2 to 51.3 per 100 000 person-years
(Table 1). The age-adjusted HR for women was 0.99 (95%
confidence interval, 0.82 to 1.20) in comparison to men.
Blood pressure. Age and sex-adjusted HRs for SAH
increased with systolic and diastolic BP values (measured at
enrolment) (Table 3). For the highest systolic ($159 mmHg) and
diastolic ($95 mmHg) BP fifths, the age and sex-adjusted HRs
were 2.43 and 2.07, respectively (Table 3), in comparison to the
lowest fifths of systolic (#122 mmHg) and diastolic (#74 mmHg)
BP. Previously diagnosed hypertension increased the risk of SAH
(Table 3).
Smoking and alcohol consumption. Current smoking at
enrolment increased the risk of SAH in comparison to never-
smokers (Table 3). 82.7% of male and 39.8% of female SAH cases
were ever-smokers at enrolment. 66.8% and 29.8% of all males
and females in the cohort, respectively, were ever-smokers.
People using 87 grams or more pure alcohol per week
(approximately 8 standard drinks per week) had a HR of 1.95
(Table 3) in comparison to abstainers. The HR was higher for
women than men who used$87 grams alcohol per week (Table 3).
Subgroup analyses by smoking status were not possible as only five
out of 43 SAH cases, who reported increased alcohol use ($87 g/
week) at enrolment, were never-smokers.
Other potential risk factors. Previously experienced myo-
cardial infarction was a predictor of a future SAH (Table 3).
Premature stroke (any kind) in mother had a HR of 1.57 for SAH,
whereas premature stroke (any kind) in father did not increase the
risk of SAH significantly (Table 3). Cholesterol levels higher than
6.22 mmol/l increased the risk of SAH, especially among men
(Table 3).
Table 2. Prevalence of risk factors in the study cohort.
Risk factor (cases) Subcategory Overall %
Systolic BP (437) #122 mmHg 20.21%
123–134 mmHg 23.36%
135–144 mmHg 18.70%
145–158 mmHg 19.28%
$159 mmHg 18.46%
Diastolic BP (437) #74 mmHg 22.40%
75–82 mmHg 23.02%
83–88 mmHg 18.57%
89–94 mmHg 16.56%
$95 mmHg 19.45%
Diagnosed hypertension (428) 32.74%
Previous myocardial infarction (299)` 2.51%
Previous stroke (296)` 1.26%
Premature stroke in mother (416) 5.98%
Premature stroke in father (425) 5.97%
Myocardial infarction in mother (421) 11.74%
Myocardial infarction in father (425) 22.57%
Smoking (427) Never 52.35%
Quit .6 months ago 16.71%
Quit ,6 months ago 1.83%
Occasionally 1.96%
Daily (current) 27.15%
Alcohol consumption per week
(171)``
Non-user 42.19%
1–36 grams 19.52%
37–86 grams 18.34%
$87 grams 19.95%
Cholesterol levels (436) #4.92 mmol/l 20.08%
4.93–5.58 mmol/l 20.02%
5.59–6.22 mmol/l 19.91%
6.23–7.06 mmol/l 20.00%
$7.07 mmol/l 19.99%
BMI (437) 18.5–24.9 kg/m2 41.82%
,18.5 kg/m2 0.81%
25–29.9 kg/m2 39.58%
$30.0 kg/m2 17.79%
`Data from the surveys available from 1977 to 2007, and `` from 1982 to 2007.
doi:10.1371/journal.pone.0073760.t002
New SAH Risk Factors
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A history of prior stroke (any kind) had no significant association
with a future SAH event (Table 3). Premature myocardial
infarction in father or mother did not increase the risk of SAH
(Table 2). BMI did not affect the risk of SAH (Table 3).
Multivariate Analyses of Risk Factors for SAH
Due to the commonly known high correlation between systolic
and diastolic BP values, only systolic BP values were selected for
the multivariate analyses. All factors identified in the univariate
analyses were included in multivariate analyses. Analyses were
further stratified by sex, given the known differences in risk factor
distributions between men and women. The first multivariate
analysis indicated that alcohol consumption retained its signifi-
cance (HR 1.83) as a SAH risk factor (Table 4). However, since
data on alcohol consumption and previous myocardial infarction,
too, were not available for all identified 437 SAH cases, the first
multivariate analysis included only 145 cases. The second
multivariate analysis, in which data on alcohol consumption and
previous myocardial infarction were excluded, included 401 cases
with all covariates (Table 5). Both first and second multivariate
Table 3. Major risk factors for SAH. Overall univariate analysis adjusted for age and sex.
Risk factor (cases) Subcategory Overall (CI) Women (CI) Men (CI)
Systolic BP (437) #122 mmHg 1 1 1
123–134 mmHg 1.30 (0.91–1.86) 1.16 (0.73–1.83) 1.52 (0.83–2.80)
135–144 mmHg 1.66{ (1.17–2.38) 1.37 (0.85–2.21) 2.01* (1.12–3.63)
145–158 mmHg 1.64{ (1.14–2.33) 1.62* (1.03–2.55) 1.70 (0.93–3.10)
$159 mmHg 2.43{ (1.72–3.41) 2.50{ (1.64–3.83) 2.33{ (1.28–4.24)
Diastolic BP (437) #74 mmHg 1 1 1
75–82 mmHg 1.07 (0.74–1.53) 0.83 (0.52–1.32) 1.50 (0.83–2.71)
83–88 mmHg 1.36 (0.96–1.95) 1.36 (0.87–2.12) 1.39 (0.77–2.54)
89–94 mmHg 1.66{ (1.18–2.35) 1.56* (1.01–2.43) 1.84* (1.04–3.27)
$95 mmHg 2.07{ (1.49–2.88) 1.87{ (1.23–2.86) 2.38{ (1.38–4.12)
Diagnosed hypertension (428) 1.65{ (1.36–2.00) 1.92{ (1.48–2.49) 1.35* (1.00–1.82)
Previous myocardial infarction (299)` 2.23{ (1.27–3.93) 3.34{ (1.46–7.60) 1.77 (0.82–3.81)
Previous stroke (296)` 2.17 (0.97–4.90) 4.02{ (1.64–9.86) 0.66 (0.09–4.74)
Premature stroke in mother (416) 1.57{ (1.13–2.17) 1.50 (0.98–2.32) 1.65* (1.00–2.71)
Premature stroke in father (425) 1.23 (0.85–1.79) 0.98 (0.57–1.68) 1.56 (0.94–2.61)
Myocardial infarction in mother (421) 1.16 (0.86–1.55) 0.95 (0.63–1.43) 1.46 (0.97–2.20)
Myocardial infarction in father (425) 1.03 (0.81–1.30) 1.13 (0.83–1.55) 0.92 (0.64–1.31)
Smoking (427) Never 1 1 1
Quit .6 months ago 1.33 (0.96–1.84) 0.95 (0.51–1.76) 1.62* (1.03–2.56)
Quit ,6 months ago 1.82 (0.89–3.73) 1.85 (0.59–5.81) 1.91 (0.75–4.88)
Occasionally 1.95* (1.06–3.59) 1.52 (0.62–3.73) 2.66* (1.12–6.35)
Daily (current) 2.78{ (2.21–3.50) 3.08{ (2.30–4.11) 2.74{ (1.87–4.03)
Alcohol consumption per week (171)`` Non-user 1 1 1
1–36 grams 1.05 (0.67–1.65) 0.88 (0.48–1.60) 1.40 (0.70–2.79)
37–86 grams 1.42 (0.93–2.18) 1.17 (0.61–2.22) 1.69 (0.92–3.09)
$87 grams 1.95{ (1.29–2.96) 3.14{ (1.70–5.78) 1.66* (0.95–2.93)
Cholesterol levels (436) #4.92 mmol/l 1 1 1
4.93–5.58 mmol/l 1.15 (0.79–1.69) 1.18 (0.74–1.88) 1.09 (0.56–2.12)
5.59–6.22 mmol/l 1.38 (0.96–1.99) 1.05 (0.65–1.68) 1.97* (1.10–3.53)
6.23–7.06 mmol/l 1.49* (1.05–2.12) 1.23 (0.78–1.94) 1.90* (1.07–3.40)
$7.07 mmol/l 1.55* (1.10–2.20) 1.13 (0.71–1.78) 2.26{ (1.28–3.98)
BMI (437) 18.5–24.9 kg/m2 1 1 1
,18.5 kg/m2 1.03 (0.33–3.22) 1.32 (0.42–4.18) N/A
25–29.9 kg/m2 1.04 (0.84–1.28) 1.06 (0.79–1.42) 1.00 (0.74–1.35)
$30.0 kg/m2 0.97 (0.82–1.20) 0.94 (0.65–1.35) 0.98 (0.63–1.52)
The results for women and men are derived from separate age-adjusted univariate analyses in women and men. Hazard ratios and 95% confidence intervals (CI). Total
number of cases with information on the risk factor in parenthesis. BP = blood pressure.
*P,0.05,
{P,0.01,
`Data from the surveys available from 1977 to 2007, and `` from 1982 to 2007.
N/A, not applicable (too limited number of cases).
doi:10.1371/journal.pone.0073760.t003
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analyses showed that in addition to female sex, high
($159 mmHg) systolic BP, previously diagnosed hypertension,
history of premature stroke (any kind) in mother, elevated
cholesterol levels in men, and current smoking remained
statistically significant risk factors for SAH (Table 4 and 5).
Variation in SAH Incidence Depending on Risk Factors
We stratified the study sample by risk factor status and analyzed
the incidence of SAH in various subgroups of the population-
based cohort (Fig. 1). For example, never-smoking men with low
systolic BP (#122 mmHg) had SAH incidence of 8 per 100 000
person-years, whereas SAH incidence in smoking women with
high systolic BP ($159 mmHg) was 171 per 100 000 person-years
(Fig. 1).
Discussion
The presented results of this third large and long-term cohort
study strengthen the previous [1,2] prospective findings showing
that female sex, high BP, and current smoking are major risk
factors for SAH. Major risk factors appear to have a much
stronger association with the incidence of SAH than is ordinarily
seen in cardiovascular diseases, as the incidence of SAH varies
substantially according to an individual risk factor profile. For
example, smoking women with high systolic BP had 171 SAH
cases per 100 000 person-years. Even though this study did not
assess the risk of SAH in patients with unruptured intracranial
aneurysms, these findings may be of assistance when estimating
the risk of SAH in a patient with an unruptured aneurysm. Recent
results from the prospective Norwegian study are in accordance
with ours, and suggest that the risk of SAH increases exceptionally
with a specific combination of risk factors [6]. Instead of
calculating possible interactions using hazard ratio -based algo-
rithms [6], we presented sex and risk factor -dependent incidence
variations, which may be more applicable in clinical practice.
National and cross-national differences for example in age,
diagnostic accuracy of SAH, male-to-female ratio, smoking rates
and prevalence of hypertension may partly explain the large
variation in reported SAH incidences [7] between countries. The
current results also suggest that previous myocardial infarction,
elevated serum cholesterol levels especially in men and history of
premature stroke (any kind) in mother are potential new risk
factors for SAH. If these risk factors prove to be true in non-
Finnish prospective studies, too, the etiology of SAH may need to
be seen differently.
A recent large population-based cohort study suggests that
smoking women have a higher risk of SAH than smoking men [8].
Interestingly, also the risk of coronary heart disease appears to be
higher in smoking women than in smoking men [9]. Similar to the
previous finding in the Mini-Finland study [1], the age-adjusted
(not adjusted for other risk factors) risk of SAH was almost
identical in women (HR 0.99 for women) and men. However,
Table 4. Multivariate analysis of the major risk factors for SAH.
Risk factor Subcategory Overall (CI) Women (CI) Men (CI)
Systolic BP #122 mmHg 1 1 1
123–134 mmHg 1.97* (1.08–3.66) 1.61 (0.76–3.41) 3.31 (0.97–11.24)
135–144 mmHg 2.07* (1.09–3.91) 1.17 (0.48–2.86) 4.07* (1.21–13.72)
145–158 mmHg 1.78 (0.92–3.46) 1.86 (0.80–4.30) 2.31 (0.65–8.22)
$159 mmHg 2.64{ (1.36–5.11) 2.75* (1.20–6.31) 3.44 (0.97–12.17)
Diagnosed hypertension 1.46* (1.02–2.09) 1.84* (1.09–3.09) 1.14 (0.68–1.90)
Previous myocardial infarction 3.07{ (1.57–5.98) 4.50{ (1.59–12.77) 2.60* (1.10–6.16)
Premature stroke in mother 2.08* (1.19–3.64) 2.37* (1.16–4.81) 1.71 (0.68–4.27)
Smoking Never 1 1 1
Quit .6 months ago 1.27 (0.76–2.15) 1.11 (0.46–2.68) 1.20 (0.60–2.42)
Quit ,6 months ago 2.54 (0.90–7.13) 3.77 (0.89–15.98) 1.75 (0.40–7.65)
Occasionally nc nc nc
Daily (current) 3.10{ (2.07–4.65) 3.92{ (2.28–6.74) 2.28{ (1.25–4.17)
Alcohol consumption/week Non-user 1 1 1
#36 grams 1.30 (0.80–2.11) 0.99 (0.52–1.90) 1.85 (0.86–3.95)
37–86 grams 1.58 (0.99–2.51) 1.17 (0.59–2.33) 2.01* (1.02–3.97)
$87 grams 1.83* (1.15–2.92) 2.30* (1.17–4.53) 1.75 (0.91–3.37)
Cholesterol levels #4.92 mmol/l 1 1 1
4.93–5.58 mmol/l 0.94 (0.56–1.56) 1.02 (0.55–1.89) 0.80 (0.32–1.97)
5.59–6.22 mmol/l
6.23–7.06 mmol/l
0.98 (0.58–1.63)
1.04 (0.62–1.75)
0.49 (0.22–1.08)
0.78 (0.38–1.58)
1.82 (0.85–3.89)
1.51 (0.68–3.35)
$7.07 mmol/l 0.95 (0.53–1.68) 0.51 (0.21–1.22) 1.73 (0.75–4.00)
Hazard ratios for all significant risk factors in the univariate analysis are presented, and the analysis includes FINRISK cohorts from 1982 to 2007 (Number of SAH cases
with no missing covariate data = 145). There were no subjects who reported occasional smoking in this analysis (nc = no cases), as they were few in overall number in
the study. Overall analysis adjusted for age, sex and all covariates in the table. The results for women and men are derived from separate multivariate analyses in women
and men. 95% confidence intervals (CI).
*P,0.05,
{P,0.01.
doi:10.1371/journal.pone.0073760.t004
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when adjusted for age and major risk factors in the multivariate
analyses, female sex emerges as a significant baseline variable
associated with an increased risk (HR 1.39–1.50) of SAH, as
expected. Opposite to the findings of the previous prospective
studies [1,2], SAH incidence did not associate with baseline BMI.
BMI values between current, former and never smokers may
Table 5. Multivariate analysis of the major risk factors for SAH.
Risk factor Subcategory Overall (CI) Women (CI) Men (CI)
Systolic BP #122 mmHg 1 1 1
123–134 mmHg 1.26 (0.87–1.83) 1.18 (0.74–1.90) 1.37 (0.74–2.52)
135–144 mmHg 1.51* (1.04–2.20) 1.37 (0.83–2.26) 1.64 (0.90–2.99)
145–158 mmHg 1.43 (0.98–2.09) 1.56 (0.95–2.55) 1.33 (0.72–2.45)
$159 mmHg 1.89{ (1.29–2.77) 2.00{ (1.22–3.28) 1.81 (0.97–3.37)
Diagnosed hypertension 1.49{ (1.20–1.85) 1.73{ (1.29–2.33) 1.23 (0.88–1.71)
Premature stroke in mother 1.45* (1.04–2.03) 1.42 (0.92–2.19) 1.51 (0.91–2.53)
Smoking Never 1 1 1
Quit .6 months ago 1.37 (0.97–1.94) 1.02 (0.53–1.96) 1.42 (0.89–2.28)
Quit ,6 months ago 2.11* (1.03–4.33) 2.30 (0.73–7.27) 1.85 (0.72–4.74)
Occasionally 2.33{ (1.26–4.30) 1.89 (0.77–4.63) 2.68* (1.12–6.39)
Daily (current) 3.10{ (2.43–3.95) 3.67{ (2.70–4.99) 2.53{ (1.71–3.76)
Cholesterol levels #4.92 mmol/l 1 1 1
4.93–5.58 mmol/l 1.02 (0.69–1.53) 0.99 (0.61–1.61) 1.09 (0.54–2.22)
5.59–6.22 mmol/l 1.22 (0.84–1.78) 0.88 (0.54–1.44) 1.90* (1.02–3.56)
6.23–7.06 mmol/l 1.28 (0.88–1.84) 0.98 (0.61–1.58) 1.85 (0.99–3.43)
$7.07 mmol/l 1.40 (0.97–2.01) 0.99 (0.62–1.59) 2.18* (1.19–4.00)
Hazard ratios for all other risk factors but alcohol and previous myocardial infarction are presented (Number of SAH cases with no missing covariate data = 401), and the
analysis includes all FINRISK cohorts from 1972 to 2007. Overall analysis adjusted for age, sex and all covariates in the table. The results for women and men are derived
from separate multivariate analyses in women and men. 95% confidence intervals (CI). *P,0.05, {P,0.01.
doi:10.1371/journal.pone.0073760.t005
Figure 1. Crude SAH incidences in 25-year-old and older people on the basis of risk factor profiling. Error bars represent 95%
confidence intervals. sBP* = systolic blood pressure $159 mmHg. sBP{= systolic blood pressure #122 mmHg. smoking= current smoking.
matstroke= history of premature stroke (any kind) in mother.
doi:10.1371/journal.pone.0073760.g001
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differ, and even if adjustment is made for current smoking status,
changes in smoking habits may confound results suggesting an
association between the SAH risk and BMI values.
The current study may have some advances in comparison with
the two previous large cohort studies [1,2]. First, we present a risk
factor-based analysis of the variation in the incidence of a future
SAH, which underlines the vast difference in the risk of SAH on
the basis of risk factors. Such risk factor profiling has not been
done in previous prospective studies. Second, the used National
FINRISK Study cohort has the highest number of SAH events
(n = 437), which, however, is still a limited number. Third, our
study has the longest maximal follow-up time of 38 years. In
general, our and previous [1,2] cohort studies may provide more
trustworthy evidence on SAH risk factors than numerous
retrospective case-control studies, in part since collecting pre-
morbid risk factor exposure data after a SAH event, especially
when a fatal one, is often unreliable or even impossible in a
retrospective study setup.
The current study has a number of limitations. First, the
independent effect of increased alcohol use on the SAH risk could
not be reliably determined, as it was difficult to tease apart the
effect of smoking and alcohol, since only 12% of our SAH cases
with high ($87 grams alcohol/week) consumption were never-
smokers. The multivariate analysis, in general, cannot fully adjust
for all confounding factors, but does provide guidance on the
relative importance of individual risk factors. Second, the study is a
prospective one, but based on baseline pre-morbid data collection,
not on longitudinal assessments. Therefore, no detailed exposure
data for example of smoking was available, and thus single
baseline risk factor measurements/assessments probably skew the
value of assessed modifiable risk factors in predicting a future SAH
event in this study. However, the data is still likely to be more
reliable than in retrospective case-control studies, as already
mentioned, and the previous large cohort studies [1,2] are
methodologically similar to ours. Third, in this study, the diagnosis
of SAH was based on national registers, which are known to have
errors. The accuracy of register-based diagnosis of SAH has been
relatively high (79% and .90% accuracy for the Hospital
Discharge Register and death certificates, respectively) at the era
of the ICD-8 and ICD-9 diagnostic criteria [10], and when we
assessed the data based only on ICD-10 diagnostic criteria
(theoretically more reliable for diagnoses of aneurysmal SAHs),
the results and conclusions remained practically the same (results
not shown). Despite all this, the current study may include a small
number of e.g. traumatic and non-aneurysmatic SAH cases, and
thus overestimate the incidence of SAH and underestimate the
impact of cardiovascular risk factors on SAH incidence and its
variability. Fourth, the cohort size is still too limited to make more
detailed risk factor profiling and subsequent risk analyses. Fifth,
the study results may not be applicable to other than Finnish
people. The incidence of SAH is commonly believed to be higher
in Finland than elsewhere, even though the lack of national
hospital and death registries (including autopsy reports for sudden
deaths) in most of the world’s countries makes incidence
comparisons difficult. The reported crude incidence of 34.8 per
100 000 person-years and the European standard population -
adjusted incidence of 19.0 per 100 000 person-years among $25-
year-old persons is comparable to the previously reported
incidence of SAH in Finland, [1]. Sixth, the used stratification
of BP and cholesterol levels into categories does not base on
clinical cut-off values but quintiles. This may be acceptable as
clinical cut-off values vary between countries and eras.
To conclude, female sex, high BP, and smoking are major risk
factors for SAH, as already known previously, whereas previous
myocardial infarction, elevated serum cholesterol levels especially
in men and history of premature stroke (any kind) in mother may
be new risk factors for SAH. These results suggest that SAH risk
factors are somewhat similar to other cardiovascular diseases. The
applicability of the presented risk factor profiling in identifying
high-risk subjects of a future SAH may be worth studying in
future, for example when planning screening and treatment
strategies of unruptured intracranial aneurysms. Remarkable risk
factor-dependent interindividual differences in the risk of SAH
may have confounded the results and interpretations of some
previous SAH studies.
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